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Abstract
Background: As a species, Mycobacterium tuberculosis is more diverse than previously thought. In particular, the Beijing
family of M. tuberculosis strains is spreading and evoluating throughout the world and this is giving rise to public health
concerns. Genetic diversity within this family has recently been delineated further and a specific genotype, called Bmyc10,
has been shown to represent over 60% of all Beijing clinical isolates in several parts of the world. How the host immune
system senses and responds to various M. tuberculosis strains may profoundly influence clinical outcome and the relative
epidemiological success of the different mycobacterial lineages. We hypothesised that the success of the Bmyc10 group
may, at least in part, rely upon its ability to alter innate immune responses and the secretion of cytokines and chemokines
by host phagocytes.
Methodology/Principal Findings: We infected human macrophages and dendritic cells with a collection of genetically well-
defined M. tuberculosis clinical isolates belonging to various mycobacterial families, including Beijing. We analyzed cytokine
and chemokine secretion on a semi-global level using antibody arrays allowing the detection of sixty-five immunity-related
soluble molecules. Our data indicate that Beijing strains induce significantly less interleukin (IL)-6, tumor necrosis factor
(TNF), IL-10 and GRO-a than the H37Rv reference strain, a feature that is variously shared by other modern and ancient M.
tuberculosis families and which constitutes a signature of the Beijing family as a whole. However, Beijing strains did not differ
relative to each other in their ability to modulate cytokine secretion.
Conclusions/Significance: Our results confirm and expand upon previous reports showing that M. tuberculosis Beijing
strains in general are poor in vitro cytokine inducers in human phagocytes. The results suggest that the epidemiological
success of the Beijing Bmyc10 is unlikely to rely upon any specific ability of this group of strains to impair anti-mycobacterial
innate immunity.
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Introduction
Mycobacterium tuberculosis is the most frequent cause of tubercu-
losis (TB) in humans. According to the most recent WHO
statistics, this bacterium is responsible for nearly 1.5 million deaths
and 10 million new cases every year worldwide [1]. Improvement
in the understanding of the pathogenesis of M. tuberculosis and its
interaction with its human host will undoubtedly help in the
development of novel drugs and vaccines to control TB. In recent
years, it has become more apparent that M. tuberculosis is a more
diverse species than previously thought [2]. Indeed, lineages of M.
tuberculosis can be identified on the basis of genetic and genomic
differences, including single nucleotide polymorphisms (SNPs) and
large sequence polymorphisms [3,4,5,6,7,8]. Different M. tubercu-
losis lineages are more prevalent in specific geographical regions,
and have been accordingly named Indo-Oceanic, East Asian, East
African-Indian, Euro-American, and West African lineages [2].
They have also been shown to be preferentially associated with
specific human populations, suggesting adaptation to human host
genotypes [7,9,10]. To which extend the immune response is
adapted to these different lineages is starting to be explored. Such
insights may provide significant help for developing novel
intervention strategies.
The East Asian lineage, which predominantly includes the
‘‘Beijing’’ family of M. tuberculosisstrains, is distributed mainly in east
and southeast Asia, where it may account for 50% of all strains
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13594isolated in this region [11]. In recent years, Beijing strains have
spread to many other parts of the world, including the US, Western
Europe, and South Africa, and this accounts for over 13% of all M.
tuberculosis strains worldwide [11,12,13]. Both immigrant and non-
immigrant populations are affected and this raises a major public
healthconcern.Clinicalstudieshavesuggested thatpatientsinfected
with Beijing strains may be more prone disease progression [14,15],
more likely to have smear-positive sputa [16], have higher risk of
developing extrapulmonary TB [17], and are less likely to be
successfully treated [16,18]. Taken together these observations
suggest that Beijing strains of M. tuberculosis are hypervirulent.
Studies in animal models have confirmed hypervirulence of Beijing
strains as compared to other clinical isolates [11]. Other
mechanisms that could account for the epidemiological success of
Beijing strains include accumulation of drug resistance, adaptation
to human immunity genes and genotypes, and the capacity to elicit
different innate and adaptive immune responses compared with
other M. tuberculosis strains (reviewed in [11]).
Cytokines and chemokines secreted by innate immune cells, such
as macrophages (MQ) and dendritic cells (DC) play a crucial part in
the host defenseagainst M. tuberculosis [19,20]. Differential induction
of these molecules could contribute to variations in virulence,
granuloma formation, and latency versus immunopathology and
transmission. A number of studies in cells from mice and humans
have concluded that, compared with reference strains, Beijing
strains induce more type 1 interferon and less inflammatory
cytokines, namely tumor necrosis factor (TNF), interleukin (IL)-1b,
IL-12p40, IL-6 and IL-10. [21,22,23,24,25,26,27,28,29]. The most
commonly used reference strains in these studies were H37Rv and
CDC1551. The mechanisms underlying the characteristics of
Beijing strains are not fully understood, and may involve the
production of specific lipids [24,30,31].
In the present study, we further explored the innate immune
response to the Beijing family of M. tuberculosis strains. The strains
of this family have recently been clustered into over 20 genotypes/
groups on the basis of SNPs identified in DNA replication,
recombination and repair genes ([8]). One such group (named
Bmyc10) appears to be largely over-represented, and represents
over 60% of all Beijing strains that have been analyzed, regardless
of their geographical origin. Another Beijing group, Bmyc25,
represents 9% of the Beijing strains analyzed and includes the
Gran Canaria outbreak strain GC1237 [32]. The clear recent
expansion of the Bmyc10 group, and, to a lesser extend, the
Bmyc25 group, as compared with ancestral Beijing groups (Table
S1), suggests that these subfamilies may be more adapted to their
human hosts. We hypothesized that the Bmyc10 and possibly
Bmyc25 strains might differ from other ancestral and minor
Beijing subfamilies in their ability to stimulate innate immune cells
and induce MQ and DC cytokine/chemokine secretion. In our
investigations, we used a combination of semi-global protein array-
and ELISA-based assays, as well as an in vitro model of granuloma
formation. Among the 65 cytokines and other immune mediators
that were analyzed, we did not find a single molecule that was
differentially modulated by Bmyc10 or Bmyc25 strains, compared
with other Beijing strains. However, we confirmed that low
production of TNF, IL-6 and IL-10 by infected human MQ and
DC in vitro is a signature of the Beijing family as a whole. We also
report that Beijing strains consistently induce less GRO-a,a s
compared with H37Rv and other M. tuberculosis lineages.
Results and Discussion
Based on the phylogenetic tree of the Beijing family that has
been recently constructed by Mestre et al. [33], a total of nine
representative strains were selected from the different subfamilies.
These included two strains from the over-represented modern
groups Bmyc10 and Bmyc25, two strains from the ancestral group
Bmyc4, and three strains from three minor groups, namely
Bmyc3, Bmyc9 and Bmyc13 (Table S1). Human monocytes were
collected from healthy blood donors and differentiated into MQ in
the presence of monocyte-colony stimulating factor (M-CSF). MQ
were infected with the different strains at a multiplicity of infection
(MOI) of 5 bacteria per cell. At 4 h and 18 h following infection,
the culture medium was collected and analyzed for cytokine/
chemokine content using dedicated antibody arrays, which could
assay a total of 65 cytokines, chemokines, growth factors and other
soluble immune mediators. The signals were captured with X-ray
films (Figure 1A), and quantified by densitometry (Figure 1B–F).
Thirty-four molecules were detected at varying levels in the
supernatants of infected cells at 4 h and 18 h post-infection
(Table 1& Table S2). Production of IL-6, IL-10 and GRO-a by
MQ at 18 h after infection was significantly less for Beijing strains
than for H37Rv (Figure 1C–E). The production of other
molecules, such as monocyte chemotactic protein (MCP)-1
(Figure 1F) did not differ between H37Rv and Beijing strains,
indicating that cells had been infected at comparable MOI. We
also confirmed that, as previously reported, Beijing strains induce
less TNF than H37Rv in MQ after 18 h infection (Figure 1B),
although this was barely visible in the protein arrays (Figure 1A).
All these results were confirmed by ELISA in two subsequent
independent experiments (Figure 2). These findings suggest that, as
previously reported, Beijing strains induce less TNF, IL-6 and IL-
10 in vitro in MQ than H37Rv. In addition we found that Beijing
strains also induce less GRO-a than the reference strain, and this
has not been previously reported. No differences were observed
among the Beijing strains, except minor variations, notably GRO-
a production (Figure 1E), which were not confirmed by ELISA
quantification.
Human monocyte-derived DC generated in the presence of
granulocyte/monocyte colony-stimulating factor (GM-CSF) and
IL-4 were used in similar experiments. The complete set of data is
shown in Table S3. The results for DC were similar with lower
production of TNF and IL-6 following infection with Beijing
strains compared to H37Rv (Table S3 & Figure S1). GRO-a was
not detected in the supernatant of infected DC but slight
differences between H37Rv- and Beijing-infected cell supernatants
were observed for the ‘‘GRO’’ spot on the membranes, which
suggest that cells may differentially secrete either GRO-b/MIP-
2a/CXCL2 or GRO-c/MIP-2b/CXCL3 or both. In addition,
MIP-1a secretion was diminished in DC infected with the Beijing
strains as compared to with H37Rv (Table S3), which was
confirmed by ELISA (Figure S1). No differences in IL-10
production were observed (data not shown).
These results confirm and expand upon previous studies, and
show that the Beijing strains of M. tuberculosis are weak cytokine
producers compared to the H37Rv reference strain, at least
regarding TNF, IL-6, IL-10 and GRO-a.
We next assessed whether such a signature was specific to the
Beijing family or was common to other M. tuberculosis lineages. The
Euro-American lineage, to which H37Rv belongs, and the East-
Asian lineage (Beijing) are both considered as ‘‘modern’’ M.
tuberculosis lineages, lacking in particular the TbD1 genomic region
[7,34]. We wanted to extend our investigations to other ‘‘modern’’
M. tuberculosis families (Haarlem and LAM families) and to an
‘‘ancient’’ family (the EAI family, belonging to the Indo-Oceanic
lineage). We infected human MQ with 16 strains from these
families (Table S1), in addition to H37Rv and Beijing strains, and
compared the cytokine/chemokine production profiles. As shown
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strains with respect to cytokine/chemokine secretion. The
Haarlem and most of the LAM strains induced similar cytokine
levels to H37Rv, consistent with these strains belonging to the
Euro-American lineage. However two of the LAM strains induced
cytokine levels that were closer to those observed with the Beijing
strains. A strong heterogeneity was also observed in the ancient
EAI strains, with some strains inducing H37Rv-like profiles of
cytokine secretion, and other inducing Beijing-like profiles
(Figure 3). As a whole, about two thirds of the non-Beijing strains
induced higher cytokine/chemokine levels than the Beijing
strains, while the others induced comparable cytokine/chemokine
levels. Thus, among the different lineages of M. tuberculosis, the
Beijing strains are homogeneous low-cytokine/chemokine
inducers.
Finally, because some of the differentially induced immune
mediators, such as TNF, are involved in granuloma formation, we
assessed whether differential cytokine secretion correlates with in
vitro granuloma formation. Following a previously described
procedure [35], we infected total peripheral blood mononuclear
cells (PBMC) with different Beijing and non-Beijing strains at a
MOI of 1 bacterium/2,000 cells, and monitored granuloma
formation (Figure 4A) over time. The number (Figure 4B) and size
(Figure 4C) of granulomas induced by the different strains was
found to be similar.
Taken together, our results show that following infection of
human MQ and DC, the Beijing group Bmyc10 is similar to the
Bmyc4 ancestral group and the other minor groups in terms of
cytokine/chemokine production and in vitro granuloma formation,
at least at the early time-points examined here; we cannot exclude
that longer infection times may have revealed differences in
production of other specific cytokines (e.g. IL-12). The Bmyc10
subfamily represents over 60% of the Beijing clinical isolates in
several parts of the world. This suggests that this subfamily may
have an evolutionary advantage compared with the other Beijing
groups. Our data indicate that this advantage does not depend
upon a differential ability of Bmyc10 strains to impair production
of cytokines and other immune mediators in innate immune cells
as opposed to other Beijing groups. However, we cannot conclude
that the in vivo immune response to Bmyc10 strains is the same as
that to other Beijing. This indicates the need for further
investigations using animal models of TB. Another possibility is
that specific mutations in DNA replication, recombination and
repair genes, such as the Bmyc10-specific Gly
58PArg mutation in
the mutT2 gene, have conferred a selective advantage to these
strains by leading to transient mutator phenotypes resulting in
strain evolution [33].
We also report that Beijing strains, regardless of subfamily,
commonly induce lower levels of TNF, IL-6, IL-10 and GRO-a
compared with H37Rv strain. Experiments including additional
strains outside the Beijing family showed that the low cytokine-
production is a uniform signature of this family. These results were
found in human monocyte-derived MQ and DC, and confirm and
expand upon previous reports that used other in vitro and ex vivo cell
model systems not including monocyte-derived MQ and DC
Figure 1. Semi-global protein analysis reveals differences in the cytokine/chemokine profile of MQ infected with either M.
tuberculosis H37Rv or the Beijing strains. Human MQ were infected with either M. tuberculosis H37Rv or representive Beijing strains for 18 h and
the cell culture supernatants were analyzed for cytokine/chemokine content using Human Cytokine Antibody Array 3. The detection signals were
captured with X-ray films. A) Representative membrane scanning analysis of supernatants from cells infected with H37Rv (left panel) and the W4
(Beijing, Bmyc10 group, right panel) strains. +, positive control spots; 2, negative control spots; 1, TNF spots; 2, IL-6 spots; 3, IL-10 spots; 4, GRO-a
spots. B–E) The signals on the membranes were quantified by densitometry. Results obtained for TNF (B), IL-6 (C), IL-10 (D), GRO-a (E) and MCP-1 (F)
are shown and data represent means6s.d. of relative signal intensity of the duplicate spots. Data were analyzed using the Student’s t-test. *, P,0.05;
**, P,0.01; ***, P,0.001. The complete list of cytokine/chemokines subjected to detection by the array is presented in Table S2.
doi:10.1371/journal.pone.0013594.g001
Table 1. Cytokines, chemokines and growth factors secreted
by H37Rv- and W4 (Beijing Bmyc10)-infected human
monocyte-derived macrophages
1.
Infection time
4 h 18 h
Strain Strain
Cytokine H37Rv W4 H37Rv W4
IL-2 ND ND +/2 +/2
IL-3 +/2 +/2 +/2 +/2
IL-6 +/2 +/2 ++ /2
IL-7 +/2 +/2 +/2 +/2
IL-8 ++ ++ ++ ++
IL-10 +/2 +/2 ++
TNF-a ++ + /2 ND
I-309/CCL1 ND ND +/2 +/2
MCP-1/CCL2 + + ++ ++
MIP-1 a/CCL3 + +++
MIP-1 b/CCL4 ++ ++ ++ ++
RANTES/CCL5 +/2 +/2 ++
MCP-3/CCL7 ND ND +/2 +/2
MCP-2/CCL8 ND ND +/2 +/2
MIP-1 d/CCL15 ND ND +/2 +/2
MIP-3 a/CCL20 ND ND +/2 +/2
MDC/CCL22 +/2 +/2 +/2 +/2
Eotaxin-2/CCL24 ND ND +/2 +/2
Eotaxin-3/CCL26 +/2 +/2 +/2 +/2
GRO ++ ++ ++ ++
GRO-a/CXCL1 +/2 +/2 ++
ENA-78/CXCL5 ND ND +/2 +/2
GCP-2/CXCL6 +/2 +/2 +/2 +/2
NAP-2/CXCL7 +/2 +/2 +/2 +/2
IP-10/CXCL10 +/2 +/2 +/2 +/2
I-TAC/CXCL11 +/2 +/2 +/2 +/2
CXCL16 ND ND +/2 +/2
Fractalkine/CX3CL1 +/2 +/2 +/2 +/2
Lymphotactin/XCL1 ND ND +/2 +/2
SCF/KITLG ND ND +/2 +/2
MCSF/CSF-1 +/2 +/2 +/2 +/2
GM-CSF/CSF-2 +/2 +/2 +/2 +/2
EGF +/2 +/2 +/2 +/2
Oncostatin M ND ND +/2 +/2
1Symbols indicate relative signal intensity (RSI) in the membrane array. +/2,
weak production; 0.01,RSI,0.1; +, 0.1,RSI,0.5; ++, strong production,
RSI.0.5; ND, not detected (RSI,0.01).
doi:10.1371/journal.pone.0013594.t001
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cytokine production by Beijing strains remain to be identified;
we can anticipate that it is unlikely to rely solely on the production
of phenolic glycolipid (PGL) because we could not establish a
direct relationship between PGL production (e.g. in the W4 strain
[30]) or absence of PGL (e.g. in the N4 and NHN5 strains [30]),
and a differential ability of these strains to impair cytokine
production.
Figure 2. ELISA confirmation of differences in IL-6, IL-10, GRO-a, and TNF secreted by MQ upon infection with either M. tuberculosis
H37Rv or Beijing strains. Human MQ were infected with M. tuberculosis H37Rv or representive Beijing strains for 18 h and the cell culture
supernatants were analyzed for cytokine/chemokine content using dedicated ELISA kits. Data represent the means6s.d. of TNF (A), IL-6 (B), IL-10 (C),
GRO-a (D), and MCP-1 (E) concentration in four samples (n=4) from one representative donor out of four independent donors. Data were analyzed
using the Student’s t-test. *, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0013594.g002
Immunity to M. tuberculosis
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local inflammation and innate control of bacterial infection by
MQ, neutrophils and natural killer cells [36,37]. It also promotes
migration of antigen-specific T cells from the draining lymph node
to the site of M. tuberculosis infection where they exert adaptive
control of M. tuberculosis through granuloma formation [38]. Of the
4 cytokines and chemokines that were induced at lower levels by
the Beijing-infected MQ, TNF, IL-6 and GRO-a are proinflam-
matory [36], while IL-10 could play a regulatory role in preventing
immunophothology [36,39]. Lower induction of these cytokines by
the Beijing strains may therefore lead to either a higher local
inflammation or to a weaker innate and adaptive control of
mycobacteria resulting in a hypervirulent M. tuberculosis phenotype.
Further exploration, including in vivo investigations, is required to
determine the net effect of these multiple modulations in cytokine
secretion. The finding that GRO-a/CXCL1 and MIP-1a/CCL3
secretion is impaired in Beijing-infected cells is novel. These
chemokines are chemotactic for granulocytes, including neutro-
phils. Our results suggest that neutrophil recruitment may be
impaired or delayed in the lungs of Beijing-infected hosts, which
should also be further examined in vivo.
Materials and Methods
Mycobacteria strains and culture medium
The strains of M. tuberculosis that were used in this study are
listed in Table S1. Bacilli were cultured in Middlebrook 7H9 broth
(BD-Diagnostic Systems) supplemented with 10% Middlebrook
ADC enrichment medium (BD-Diagnostic Systems) and 0.05%
Tween-80 (Sigma-Aldrich). The H37Rv strain used here was
obtained from S. Cole (Institut Pasteur, Paris) and was the one
used in the initial M. tuberculosis genome-sequencing project. After
a limited number of in vitro expansion passages, bacteria have been
aliquoted and frozen. Aliquots were thawed and cultured 24 h
before infection, in order to minimize loss of virulence.
Preparation of monocyte derived macrophages and
dendritic cells, and cell infection
Monocytes were obtained from healthy blood donors (Etablisse-
ment Franc ¸ais du Sang, EFS, Toulouse). Written informed
consents were obtained from the donors under EFS contract
nu21/PVNT/TOU/IPBS01/2009-0052. Following articles
L1243-4 and R1243-61 of the French Public Health Code, the
contract was approved by the French Ministry of Science and
Technology (agreement nuAC 2009-921).
Monocytes were differentiated into MQ or DC following a
previously published procedure [40]. Briefly, mononuclear cells
were isolated from blood using Ficoll-Paque Plus (GE Healthcare).
Monocytes were then purified using CD14 microbeads and
MACS separation columns (Miltenyi Biotec). Monocytes were
resuspended in RPMI-1640 medium (Invitrogen) and allowed to
attach to 12-well polystyrene plates (Corning) for one hour at 37uC
(700,000 cells/well). After washing with PBS, monocytes were
cultured in RPMI-1640 medium supplemented with 10% heat-
activated human serum (Sigma-Aldrich), 1% penicillin-streptomy-
cin (Invitrogen), and 20 ng/ml M-CSF (Miltenyi Biotec) at 37uC
under a 5% CO2 humidified atmosphere. On day 3, the culture
was fed with complete medium containing a full dose of M-CSF.
On day 5, the culture medium was changed to macrophage
serum-free medium (Invitrogen) supplemented with 20 ng/ml M-
CSF. On day 6, the monocyte-derived MQ were ready for
infection. DC were differentiated following a similar procedure
Figure 3. Cytokine secretion profiles of MQ infected with various major M. tuberculosis lineages. Human MQ were infected with either M.
tuberculosis H37Rv or representive strains from the Beijing, Haarlem, LAM and EAI families for 18 h and the cell culture supernatants were analyzed for
cytokine/chemokine content using dedicated ELISA kits. Data represent the means6s.d. of IL-6 (A), IL-10 (B), GRO-a (C), and TNF (D) concentration in
four samples (n=4) from one representative donor out of two independent donors.
doi:10.1371/journal.pone.0013594.g003
Immunity to M. tuberculosis
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(20 ng/ml).
Exponentially growing mycobacteria were centrifuged and
resuspended in macrophage serum-free medium. Clumps were
disassociated by 20 passages through a 26-G needle. An OD600
value between 0.2 and 1 was measured in a dilution of the
bacterial suspension. The bacterial density in the suspension was
estimated using the equation: bacteria/ml=OD600x10
8xdilution.
Infection of the cells was performed at a multiplicity of infection
(MOI) of 5 bacteria/cell by changing the cell culture medium to a
mycobacteria suspension in 1 ml macrophage serum-free medium.
After 4 hours of incubation at 37uC, the culture medium was
collected and sterilized by filtration. The cells were fed with fresh
serum-free medium and cultured for an additional 14 h. The
culture medium was again collected and sterilized. For in vitro
granuloma formation, total PBMC were infected with the M.
tuberculosis strains at a MOI of 1 bacteria/2,000 cells and were
observed at different times after infection using a light microscope,
as previously described [35].
Semi-quantitative cytokine/chemokine antibody array
assay and quantitative ELISA
Cytokines, chemokines and other growth factors and immune
mediators present in the cell culture supernatants were assayed
using Human Cytokine Antibody Array 3 and Human Chemokine
Antibody Array 1 (RayBiotech). The individual signals were
detected on Amersham Hyperfilm ECL (GE Healthcare) and were
quantified using a GS-800 calibrated densitometer (Bio-Rad). The
positive control signal on each array was used for normalization,
according to the manufacturer’s instructions.
ELISA kits were purchased from BD Biosciences (TNF, IL-6,
IL-10, MCP-1) and R&D Systems (MIP-1a, GRO-a), and were
used for cytokine/chemokine quantification according to the
manufacturer’s recommendations.
Supporting Information
Figure S1 ELISA confirmation of differences in TNF, IL-6, and
MIP-1a secreted by DC upon infection with either M. tuberculosis
H37Rv or Beijing strains. Human DC were infected with M.
tuberculosis H37Rv or representive Beijing strains for 18 h and the
cell culture supernatants were analyzed for cytokine/chemokine
content using dedicated ELISA kits. Data represent the
means6s.d. of TNF (A), IL-6 (B), and MIP-1a (C) concentration
in four samples (n=4) from one representative donor out of two
independent donors. Data were analyzed using the Student t-test.
**, P,0.01; ***, P,0.001.
Found at: doi:10.1371/journal.pone.0013594.s001 (1.46 MB TIF)
Table S1 M. tuberculosis strains used in the study.
Found at: doi:10.1371/journal.pone.0013594.s002 (0.05 MB
DOC)
Table S2 Cytokines, chemokines and growth factors secreted by
H37Rv- and W4 (Beijing Bmyc10)-infected human monocyte-
derived macrophages.
Found at: doi:10.1371/journal.pone.0013594.s003 (0.13 MB
DOC)
Figure 4. In vitro granuloma formation upon PBMC infection
with various major M. tuberculosis lineages. Human whole PBMC
were infected with either M. tuberculosis H37Rv or representive strains
from the Beijing, Haarlem, LAM and EAI families for 4 or 10 days and
monitored for granuloma formation as observed under the light
microscope. A) Typical granulomas observed 10 days after infection; the
white arrow indicates a granuloma shown at higher magnification in
the inset. B) Data represent the means6s.d. number of granuloma at 4
and 10 days, scored in two independent observation fields. C) Data
represent the means6s.d. granuloma size 10 days after infection;
between 38 and 55 granulomas were recorded in two independent
observation fields. Data were analyzed using the Student’s t-test; no
significant differences were observed among the different conditions.
doi:10.1371/journal.pone.0013594.g004
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H37Rv- and W4 (Beijing Bmyc10)-infected human monocyte-
derived dendritic cells.
Found at: doi:10.1371/journal.pone.0013594.s004 (0.13 MB
DOC)
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